Perspective Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Perspective Therapeutics's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 80% to $1,434,000. Profit margin reached -3243%. Total operating expenses were $42,375,000.
Profit Margin
| 2015 | 4.60M | -3.68M | -79.91% |
|---|---|---|---|
| 2016 | 4.76M | -4.71M | -98.77% |
| 2018 | 5.92M | -6.7M | -113.12% |
| 2019 | 7.31M | -4.85M | -66.31% |
| 2021 | 10.05M | -3.18M | -31.71% |
| 2022 | 10.79M | -7.15M | -66.26% |
| 2022 | 7.10M | -14.67M | -206.5% |
| 2023 | 1.43M | -46.50M | -3243.24% |
CATX Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2018 | 2017 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||
Revenue | 1.43M | 7.10M | 10.79M | 10.05M | 7.31M | 5.92M | 4.76M | 4.60M |
Cost of revenue | 0 | 5.47M | 6.17M | 4.93M | 4.26M | 4.08M | 4.64M | 4.43M |
Gross profit | 1.43M | 1.63M | 4.61M | 5.12M | 3.04M | 1.84M | 129.15K | 167.39K |
Operating exp. | ||||||||
Research and development | 21.31M | 2.60M | 2.58M | 1.42M | 1.47M | 1.74M | 528.04K | 614.77K |
Selling and marketing | 97K | 3.22M | 2.80M | 2.44M | 2.67M | 2.66M | 1.35M | 1.48M |
Total operating expenses | 42.37M | 17.42M | 12.00M | 8.55M | 8.32M | 8.57M | 5.21M | 4.50M |
Operating income | -40.94M | -15.18M | -7.39M | -3.43M | -5.27M | -6.72M | -5.08M | -4.33M |
Other income (expenses), net | 835K | 512K | 119K | 50K | 134K | 29K | 154K | 374.60K |
Income before tax | -40.10M | -14.67M | -7.27M | -3.38M | -5.14M | -6.7M | -4.71M | -3.68M |
Income tax expense | -2.65M | 0 | -119K | -199K | -294K | -29K | -371.19K | -655.13K |
Net income | -46.50M | -14.67M | -7.15M | -3.18M | -4.85M | -6.7M | -4.71M | -3.68M |
Earnings per share | ||||||||
Basic EPS | -1.4 | -0.1 | -0.05 | -0.03 | -0.07 | -0.12 | -0.08 | -0.06 |
Diluted EPS | -1.4 | -0.1 | -0.05 | -0.03 | -0.07 | -0.12 | -0.08 | -0.06 |
| Data source | Data source | Data source | Data source |